Zoloft Birth Defect Litigation on the Rise
Written by Faith Anderson on October 25, 2012
Zoloft and Potential Birth Defects
Zoloft, also known by its generic sertraline, is one of the most widely prescribed antidepressant drugs on the market, with 29.6 million prescriptions filled in 2007 alone. Zoloft belongs to a class of antidepressants called SSRIs, or selective serotonin reuptake inhibitors, which represent the most popular antidepressants in the United States. Zoloft garnered approval by the U.S. Food and Drug Administration (FDA) in 1991, and is commonly used to treat major depressive disorder, anxiety and obsessive-compulsive disorder. Unfortunately, mounting research has drawn a connection between the use of Zoloft during pregnancy and the development of major birth defects in children, which is the basis for the current Zoloft litigation.
Contact a Qualified Zoloft Attorney for Legal Help
All of the Zoloft complaints in the U.S. involve similar allegations that Zoloft maker Pfizer failed to adequately warn pregnant women and medical professionals about the potential for Zoloft treatment during pregnancy to result in birth defects, claiming that the drug company knew or should have known about the risk of heart problems, neural tube birth defects, club foot, PPHN (persistent pulmonary hypertension of the newborn), spinal bifida, abdominal defects and other malformations. If you took Zoloft during pregnancy and your child was born with a serious birth defect, you may be entitled to financial compensation from Pfizer to cover the cost of your child’s medical bills and future care. Our consumer advocates at the Consumer Justice Foundation (CJF) can put you in contact with an experienced Zoloft attorney, who can discuss with you your options for legal recourse.